Home / FlashMed

FlashMed

Titolo Response to: Mortality risk for patients receiving hemodiafiltration versus hemodialysis.
Autore B. Canaud, J.L. Bragg-Gresham, M.R. Marshall, S. Desmeules, B.W. Gillespie, T. Depner, P. Klassen P, F.K. Port
Referenza Kidney International 2006; 70: 1524
Contenuto Jirka et al. submit a very interesting letter confirming the results recently reported with the International Dialysis Outcomes and Practice Patterns Study. They observed a 35.3% reduction rate in mortality risk in online hemodiafiltration (HDF)-treated patients belonging to an international dialysis care provider (Fresenius Medical Care, Bad Homburg, Germany), after adjustment for age, co-morbidities, and time on dialysis. Today, it is not still well understood why these convective therapies are superior to hemodialysis. This brief report is, nevertheless, a very strong support to our findings showing that high-efficiency convective therapies, such as online HDF, may offer an interesting alternative to improve dialysis patient outcomes.
Data 02.11.2006
 
Maggiori informazioni   
Lista completa